Print

Targacept, Inc. (TRGT) Reports Second Quarter 2012 Financial Results  
8/8/2012 10:07:14 AM

WINSTON-SALEM, N.C.--(BUSINESS WIRE)--Targacept, Inc. (NASDAQ: TRGT), a clinical-stage biopharmaceutical company developing novel NNR Therapeutics™, today reported its financial results for the second quarter and six months ended June 30, 2012.
//-->